Changing to Nonprotease Inhibitor Treatment to Improve Side Effects
Phase II, Randomized, Open-Label Study of Switching to Protease Inhibitor-Sparing Regimens for Improvement of Metabolic Abnormalities Phase II, Randomized, Open-Label Study of Switching to Protease Inhibitor-Sparing Regimens for Impro ...